Submit Deal

SCICLONE PHARMACEUTICALS INC

Summary

SciClone Pharmaceuticals is a US-based, China-focused specialty pharmaceutical company focusing on differentiated therapies for oncology, infectious, cardiovascular, urological, respiratory and central nervous system disorders.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 890 M

Avg. Deal Size£ 890 M

Market Context

Senior Management

Zhao Hong
President and CEO

Sort

zhao hong

President and CEO at SCICLONE PHARMACEUTICALS INC

Manager

Deal

£ 890 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy